Showing results (341-350 of 498) with videos related to

Sort By:
Pageof 50
Cancer Research|April 20, 2001
Overexpression of a dominant-negative signal transducer and activator of transcription 3 variant in tumor cells leads to production of soluble factors that induce apoptosis and cell cycle arrestG Niu, K H Shain, M Huang, et al.
Sleep|December 20, 2002
Prevalence of sleep problems and quality of life in an older populationCarla R Schubert, Karen J Cruickshanks, Dayna S Dalton, et al.
Journal of Medical Internet Research|April 9, 2014
Collaborative biomedicine in the age of big data: the case of cancerAbdul R Shaikh, Atul J Butte, Sheri D Schully, et al.
Journal of the American Academy of Dermatology|October 4, 2005
Oral phosphate binders in the treatment of pseudoxanthoma elasticumDaniel W Sherer, Giselle Singer, Jaime Uribarri, et al.
Archives of Neurology|March 15, 2006
Later-onset Fabry disease: an adult variant presenting with the cramp-fasciculation syndromeChristopher S Nance, Christopher J Klein, Maryam Banikazemi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
Inhibition of JAK kinase activity enhances Fas-mediated apoptosis but reduces cytotoxic activity of topoisomerase II inhibitors in U266 myeloma cellsM M Oshiro, T H Landowski, R Catlett-Falcone, et al.
Cancer Research|February 21, 2006
Cell adhesion to fibronectin (CAM-DR) influences acquired mitoxantrone resistance in U937 cellsLori A Hazlehurst, Raul F Argilagos, Michael Emmons, et al.
International Journal of Cancer|May 16, 1996
Verapamil suppresses the emergence of P-glycoprotein-mediated multi-drug resistanceB W Futscher, N E Foley, M C Gleason-Guzman, et al.
Leukemia|May 4, 2007
Bone marrow stromal cells prevent apoptosis of lymphoma cells by upregulation of anti-apoptotic proteins associated with activation of NF-kappaB (RelB/p52) in non-Hodgkin's lymphoma cellsT Lwin, L A Hazlehurst, Z Li, et al.
Cancer Research|September 1, 1989
Elimination of chemoresistant multiple myeloma clonogenic colony-forming cells by combined treatment with a plasma cell-reactive monoclonal antibody and a P-glycoprotein-reactive monoclonal antibodyA W Tong, J Lee, R M Wang, et al.
Pageof 50